EPISODE · Jul 18, 2024 · 18 MIN
The strategic negotiations behind the Allergan-Actavis merger amidst Valeant's hostile takeover bid.
from AI meets Negotiation Expertise · host Yadvinder Singh Rana
Send a textIn this episode, we'll explore the 66 billion $ merger negotiations between Allergan and Actavis, and the hostile takeover attempt by Valeant. Joining me again is my special co-host, Alex, an advanced Artificial Intelligence known as ChatGPT. Alex brings a unique perspective to our analysis, harnessing the power of AI to deepen our conversation. If you enjoyed this episode, please leave a review and check out our website: www.negoai.ai I welcome any suggestions, questions, or comments at [email protected] --------------------------------------------------------------------------------------------------Copyright Disclaimer Under Section 107 of the Copyright Act 1976, allowance is made for "fair use" for purposes such as criticism, comment, news reporting, teaching, scholarship, and research. Fair use is a use permitted by copyright statute that might otherwise be infringing.
What this episode covers
Send a text In this episode, we'll explore the 66 billion $ merger negotiations between Allergan and Actavis, and the hostile takeover attempt by Valeant. Joining me again is my special co-host, Alex, an advanced Artificial Intelligence known as ChatGPT. Alex brings a unique perspective to our analysis, harnessing the power of AI to deepen our conversation. If you enjoyed this episode, please leave a review and check out our website: www.negoai.ai I welcome any sugge...
NOW PLAYING
The strategic negotiations behind the Allergan-Actavis merger amidst Valeant's hostile takeover bid.
No transcript for this episode yet
Similar Episodes
Mar 31, 2026 ·54m
Mar 27, 2026 ·14m
Mar 24, 2026 ·42m
Mar 20, 2026 ·42m
Mar 17, 2026 ·41m
Mar 13, 2026 ·44m